(May 4, 2009 - Insidermedicine) From Washington - The FDA has approved a triple-drug polypill for the treatment of hypertension. The polypill, called Exforge HCT, contains the calcium channel blocker amlodipine, the diuretic hydrochlorothiazide and the angiotensin receptor blocker valsartan. While the polypill has been approved for the treatment of hypertension, it has not been approved as initial therapy.

From Seattle - According to research presented to the American Academy of Neurology, diet may be linked to Alzheimer's disease. In a study of over 2,100 elderly patients, researchers found that those with a diet high in vegetables, nuts and fish, but low in high-fat dairy products, had a 42% reduced risk of developing Alzheimer's.

And finally, from Atlanta - While the number of cases of H1N1 flu increased in the United States over the weekend, officials at the CDC are optimistic. The number of confirmed cases rose from 160 on Saturday to 226 on Sunday, but reports from Mexico indicate that the worst may be over. In addition, the CDC has finished delivering 25% of its antiviral drug stockpile, or 11 million regimens, to the states.

For Insidermedicine in 60, I'm Dr. Susan Sharma.